Madison Avenue Partners
Latest statistics and disclosures from Madison Avenue Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GHC, INVH, MKL, CPNG, MICC, and represent 49.87% of Madison Avenue Partners's stock portfolio.
- Added to shares of these 10 stocks: INVH (+$252M), Octave Intelligence (+$69M), CPNG (+$54M), STAA (+$50M), MKL (+$48M), SANM (+$48M), PRIM (+$46M), AD (+$40M), Galapagos Nv- (+$30M), GMED (+$17M).
- Started 7 new stock positions in MRP, PRIM, Octave Intelligence, MNRO, SANM, AD, INVH.
- Reduced shares in these 10 stocks: SNDK (-$1.4B), , , INDV (-$59M), WLY (-$26M), PRMB (-$25M), DNOW (-$16M), CBC (-$11M), SOLV (-$10M), MICC (-$9.6M).
- Sold out of its positions in CBC, FSP, MOH, DNOW, PAR, PRMB, WLY, ICLR, SN.
- Madison Avenue Partners was a net seller of stock by $-1.1B.
- Madison Avenue Partners has $2.3B in assets under management (AUM), dropping by 1.01%.
- Central Index Key (CIK): 0001801265
Tip: Access up to 7 years of quarterly data
Positions held by Madison Avenue Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Madison Avenue Partners
Madison Avenue Partners holds 25 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Graham Hldgs Com Cl B (GHC) | 12.1 | $281M | 246k | 1141.42 |
|
|
| Invitation Homes (INVH) | 10.8 | $252M | NEW | 8.3M | 30.21 |
|
| Markel Corporation (MKL) | 9.4 | $219M | +27% | 112k | 1953.01 |
|
| Coupang Cl A (CPNG) | 9.3 | $216M | +33% | 13M | 17.37 |
|
| Magnum Ice Cream Co Nv Ord Shs (MICC) | 8.2 | $190M | -4% | 11M | 17.41 |
|
| Theravance Biopharma (TBPH) | 6.7 | $157M | -3% | 9.2M | 17.00 |
|
| Solventum Corp Com Shs (SOLV) | 5.8 | $134M | -7% | 1.7M | 77.15 |
|
| Staar Surgical Com Par $0.01 (STAA) | 5.2 | $120M | +71% | 4.2M | 28.69 |
|
| Indivior Ord (INDV) | 5.1 | $118M | -33% | 2.9M | 41.03 |
|
| Lakefront Biotherapeutics Nv Spon Adr | 4.4 | $103M | +39% | 3.4M | 29.98 |
|
| Globus Med Cl A (GMED) | 3.2 | $74M | +30% | 935k | 79.01 |
|
| Octave Intelligence Ord Shs Cl B | 3.0 | $69M | NEW | 4.2M | 16.30 |
|
| British Amern Tob Sponsored Adr (BTI) | 2.8 | $64M | -7% | 1.0M | 61.76 |
|
| Stagwell Com Cl A (STGW) | 2.6 | $60M | 8.0M | 7.43 |
|
|
| Sanmina (SANM) | 2.1 | $48M | NEW | 188k | 253.08 |
|
| Primoris Services (PRIM) | 2.0 | $46M | NEW | 462k | 99.12 |
|
| United States Cellular Corporation (AD) | 1.7 | $40M | NEW | 1.1M | 36.26 |
|
| Apartment Invt & Mgmt Cl A (AIV) | 1.6 | $37M | 12M | 2.97 |
|
|
| Sandisk Corp (SNDK) | 0.9 | $22M | -98% | 9.7k | 2273.73 |
|
| Turning Pt Brands (TPB) | 0.9 | $21M | 248k | 84.81 |
|
|
| Sinclair Cl A (SBGI) | 0.8 | $20M | -6% | 1.4M | 14.25 |
|
| Magnera Corp Com Shs (MAGN) | 0.7 | $15M | -18% | 1.3M | 11.75 |
|
| Millrose Pprys Com Cl A (MRP) | 0.4 | $9.0M | NEW | 299k | 30.05 |
|
| Keros Therapeutics (KROS) | 0.3 | $6.7M | 627k | 10.70 |
|
|
| Monro Muffler Brake (MNRO) | 0.1 | $1.6M | NEW | 96k | 17.11 |
|
Past Filings by Madison Avenue Partners
SEC 13F filings are viewable for Madison Avenue Partners going back to 2019
- Madison Avenue Partners 2026 Q2 filed Aug. 14, 2026
- Madison Avenue Partners 2026 Q1 filed May 15, 2026
- Madison Avenue Partners 2025 Q4 filed Feb. 17, 2026
- Madison Avenue Partners 2025 Q3 filed Nov. 14, 2025
- Madison Avenue Partners 2025 Q2 filed Aug. 14, 2025
- Madison Avenue Partners 2025 Q1 filed May 15, 2025
- Madison Avenue Partners 2024 Q4 filed Feb. 14, 2025
- Madison Avenue Partners 2024 Q3 filed Nov. 14, 2024
- Madison Avenue Partners 2024 Q2 filed Aug. 14, 2024
- Madison Avenue Partners 2024 Q1 filed May 15, 2024
- Madison Avenue Partners 2023 Q4 filed Feb. 16, 2024
- Madison Avenue Partners 2023 Q3 filed Nov. 14, 2023
- Madison Avenue Partners 2023 Q2 filed Aug. 14, 2023
- Madison Avenue Partners 2023 Q1 filed May 15, 2023
- Madison Avenue Partners 2022 Q4 filed Feb. 14, 2023
- Madison Avenue Partners 2022 Q3 filed Nov. 14, 2022